Jiangsu Recbio Technology Co., Ltd. disclosed its February 2026 monthly return. The total authorized and issued share capital remained unchanged, standing at 626.08 million shares in total—comprising 297.94 million Domestic Shares, 12.00 million Unlisted Foreign Shares, and 316.14 million H Shares. Each share carries a par value of RMB 1.
According to the announcement, the company confirmed its public float met the 25% threshold specified by the Main Board Rules. There were no share repurchases, conversions, warrants, or other activities that altered the share capital structure during the reporting month.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments